composição farmacêutica contendo inibidor de transportador de fosfato dependente de sódio

a presente invenção refere-se a um composição farmacêutica contendo, como um ingrediente ativo, um derivado de di-hidropiridazina-3,5-diona, ou um sal do mesmo, ou um solvato destes. The present invention provides a pharmaceutical composition containing, as an active ingredient, a dihydropyridazine-...

Full description

Saved in:
Bibliographic Details
Main Authors YOSHIYUKI ONO, SHUICHI OHTOMO, NAOKI OKAMOTO, YOSHIHISA MURATA, ATSUSHI KIMBARA, SHOTA TANAKA, KENICHI NOMURA, YASUHIRO ICHIDA, KAZUTAKA TACHIBANA, NAOSHI HORIBA, NOBUYUKI HORI, YOSHIHITO OHTAKE, TAKEO HARADA, EISAKU MIZUGUCHI, HIROTAKA KASHIWAGI, MITSUAKI IDE
Format Patent
LanguagePortuguese
Published 05.12.2017
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:a presente invenção refere-se a um composição farmacêutica contendo, como um ingrediente ativo, um derivado de di-hidropiridazina-3,5-diona, ou um sal do mesmo, ou um solvato destes. The present invention provides a pharmaceutical composition containing, as an active ingredient, a dihydropyridazine-3,5-dione derivative or a salt thereof or a solvate of these, wherein the composition is administered in combination with a phosphorus adsorbent.
Bibliography:Application Number: BR20171104595